Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes

Molecular and Cellular Biochemistry

Volumn 84, Issue 2, 1988, Pages 163-171

  Singal, Pawan K ^a   Tong, Jiangang ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

adriamycin; cardiomyopathy; lipid peroxidation; sarcolemma; sialic acid; Vitamin E deficiency

Indexed keywords

DOXORUBICIN; FREE RADICAL; SIALIC ACID;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL EXPERIMENT; CARDIOMYOPATHY; CELL MEMBRANE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ULTRASTRUCTURE;

ANIMAL; CELL MEMBRANE; DOXORUBICIN; MALE; MALONDIALDEHYDE; MICROSCOPY, ELECTRON; MYOCARDIAL DISEASES; MYOCARDIUM; RATS; RATS, INBRED STRAINS; SARCOLEMMA; SIALIC ACIDS; SUPPORT, NON-U.S. GOV'T; VITAMIN E DEFICIENCY;

EID: 0024261046     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/BF00421051     Document Type: Article

References (33)

1. A clinicopathologic analysis of adriamycin cardiotoxicity
2. Adriamycin (NSC-123127) cardiotoxicity. A clinicopathologic correlation
3. Risk factors of doxorubicininduced congestive heart failure
4. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children
5. Adriamycin (NSC-123127): Mode and mechanism of action
6. Alterations in DNA synthesis in cardiac tissue induced by adriamycin and in vivo relationship to fatal toxicity
7. Subcellular effects of adriamycin in the heart: A concise review
8. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation
9. Effect of anthracycline antibiotics on oxygen radical formation in rat heart
10. Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfide oxidation
11. Free radical production from normal and adriamycin-treated rat cardiac sarcosomes
12. Spin trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs
13. One electron reduction of adriamycin. Properties of the semiquinone
14. Evidence for the production of hydroxyl radicals from adriamycin semiquinone and H2O2
15. Chemicals, drugs and lipid peroxidation
16. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response
17. Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats
18. Negatively charged sites and calcium binding in the isolated rat heart sarcolemma
19. Morphological methods for studying heart membranes
20. Estimation of product of lipid peroxidation (malonyldialdehyde) in biochemical systems
21. Effects of lanthanum on the heart sarcolemmal ATPase and calcium binding activities
22. The thiobarbituric acid assay of sialic acids
23. Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy
24. Adriamycin cardiotoxicity: possible pathogenic mechanisms
25. Direct effects of adriamycin on the rat heart sarcolemma
26. Adriamycin stimulates low-affinity Cat+ binding and lipid peroxidation but depresses myocardial function
27. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs
28. The myocardial cell surface, its histochemistry, and the effect of sialic acid and calcium removal on its structure and cellular ionic exchange
29. Myocardial cation contents during induction of calcium paradox
30. Adriamycin cardiomyopathy: implications of cellular changes in a canine model with mild impairment of left ventricular function
31. The binding of calcium ions by erythrocytes and ghost — cell membranes
32. Calcium binding to the rat liver plasma membrane